REYALBIS Trademark

Trademark Overview

On Thursday, August 2, 2018, a trademark application was filed for REYALBIS with the United States Patent and Trademark Office. The USPTO has given the REYALBIS trademark a serial number of 88062540. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 12, 2022. This trademark is owned by Kala Pharmaceuticals, Inc.. The REYALBIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of inflammation and pain; pharmaceutical preparations and substances for the relief of signs and symptoms of dry eye disease; pharmaceutical preparations and substances for the treatment of ophthalmological and ocular diseases and disorders; injectable ophthalmic pharmaceutical preparations and substances; topical ophthalmic pharmaceutical preparations and substances; topical ophthalmic pharmaceutical preparations for post-surgical treatment of the eye; topical ophthalmic pharmaceutical preparations for the treatment of dryness of the eye
reyalbis

General Information

Serial Number88062540
Word MarkREYALBIS
Filing DateThursday, August 2, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 12, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 11, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of inflammation and pain; pharmaceutical preparations and substances for the relief of signs and symptoms of dry eye disease; pharmaceutical preparations and substances for the treatment of ophthalmological and ocular diseases and disorders; injectable ophthalmic pharmaceutical preparations and substances; topical ophthalmic pharmaceutical preparations and substances; topical ophthalmic pharmaceutical preparations for post-surgical treatment of the eye; topical ophthalmic pharmaceutical preparations for the treatment of dryness of the eye

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 8, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKala Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472
Party NameKala Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events

Event DateEvent Description
Monday, September 12, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 12, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, February 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 9, 2022SOU EXTENSION 5 GRANTED
Thursday, February 3, 2022SOU EXTENSION 5 FILED
Wednesday, February 9, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 3, 2022TEAS EXTENSION RECEIVED
Tuesday, August 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 6, 2021SOU EXTENSION 4 GRANTED
Friday, August 6, 2021SOU EXTENSION 4 FILED
Friday, August 6, 2021TEAS EXTENSION RECEIVED
Wednesday, May 19, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Saturday, February 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 4, 2021SOU EXTENSION 3 GRANTED
Thursday, February 4, 2021SOU EXTENSION 3 FILED
Thursday, February 4, 2021TEAS EXTENSION RECEIVED
Friday, August 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 5, 2020SOU EXTENSION 2 GRANTED
Wednesday, August 5, 2020SOU EXTENSION 2 FILED
Wednesday, August 5, 2020TEAS EXTENSION RECEIVED
Thursday, January 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 28, 2020SOU EXTENSION 1 GRANTED
Tuesday, January 28, 2020SOU EXTENSION 1 FILED
Tuesday, January 28, 2020TEAS EXTENSION RECEIVED
Tuesday, August 6, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 11, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 11, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 22, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 6, 2019ASSIGNED TO LIE
Tuesday, April 23, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 22, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 22, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 19, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 18, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 19, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 19, 2018NON-FINAL ACTION E-MAILED
Friday, October 19, 2018NON-FINAL ACTION WRITTEN
Friday, October 19, 2018ASSIGNED TO EXAMINER
Wednesday, August 8, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 6, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

reyalbis pharmaceutical preparations substances treatment ophthalmic topical injectable disorders surgical dryness